SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
81 hedge funds and large institutions have $291M invested in scPharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+19
Holders Change %
+30.65%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
33
Increased
21
Reduced
17
Closed
14
Calls
$1.84M
Puts
$1.28M
Net Calls
+$552K
Net Calls Change
+$153K
Top Buyers
| 1 |
BlackRock
New York
|
+$16.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.82M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$8.73M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$8.27M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$6.67M |
Top Sellers
| 1 |
CAC
Cowen and Company
New York
|
-$9.88M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$4.94M |
| 3 |
Millennium Management
New York
|
-$4.46M |
| 4 |
Two Sigma Investments
New York
|
-$2.02M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.44M |
